| Therapeutic potential of targeting ß-arrestin RA Bond, EY Lucero Garcia-Rojas, A Hegde, JKL Walker Frontiers in pharmacology 10, 124, 2019 | 47 | 2019 |
| Hypoxia inducible factors as central players in the pathogenesis and pathophysiology of cardiovascular diseases EY Lucero García Rojas, C Villanueva, RA Bond Frontiers in cardiovascular medicine 8, 709509, 2021 | 24 | 2021 |
| Pathophysiology and pharmacology of G protein-coupled receptors in the heart A Grogan, EY Lucero, H Jiang, HA Rockman Cardiovascular research 119 (5), 1117-1129, 2023 | 18 | 2023 |
| A NanoBiT assay to monitor membrane proteins trafficking for drug discovery and drug development A Reyes-Alcaraz, EY Lucero Garcia-Rojas, EA Merlinsky, JY Seong, ... Communications Biology 5 (1), 212, 2022 | 12 | 2022 |
| STEMIN and YAP5SA synthetic modified mRNAs regenerate and repair infarcted mouse hearts S Xiao, R Liang, E Lucero, BK McConnell, Z Chen, J Chang, S Navran, ... The journal of cardiovascular aging 2 (3), 2022 | 10 | 2022 |
| Allosteric modulators for GPCRs as a therapeutic alternative with high potential in drug discovery A Reyes-Alcaraz, EYL Garcia-Rojas, RA Bond, BK McConnell Molecular Pharmacology, 2020 | 5 | 2020 |
| Fusion of the β2‐adrenergic receptor with either Gαs or βarrestin‐2 produces constitutive signaling by each pathway and induces gain‐of‐function in BEAS‐2B cells EYLG Rojas, A Reyes‐Alcaraz, K Ruan, BK McConnell, RA Bond FASEB BioAdvances 4 (12), 758, 2022 | 1 | 2022 |
| Allosteric Modulators for GPCRs as a Therapeutic Alternative with High Potential in Drug Discovery AR Alcaraz, EYL Garcia-Rojas, RA Bond, BK McConnell Molecular Pharmacology, 89, 2020 | 1 | 2020 |
| Phosphorylation patterns in the AT1R C-terminal tail specify distinct downstream signaling pathways C Gareri, CT Pfeiffer, X Jiang, JA Paulo, SP Gygi, U Pham, A Chundi, ... Science Signaling 17 (849), eadk5736, 2024 | | 2024 |
| B-arrestin deletion abrogates the innate immune response in murine CVB3 myocarditis D Galtes, H Jiang, E Lucero, H Rockman Physiology 38 (S1), 5731432, 2023 | | 2023 |
| Fusion Proteins as Tools to Discriminate the Biased Signaling Profile of β2 Adrenergic Receptor Ligands E Lucero Garcia Rojas, B McConnell, R Bond The FASEB Journal 35, 2021 | | 2021 |
| Fusion Proteins as Selective Inducers of Constitutive Activity and Tools to Discriminate the Biased Signaling Profile of β2 Adrenoceptor Ligands EY Lucero Garcia Rojas | | 2021 |
| Role of Distinct β2 Adrenergic Receptor Pathways in Mediating Inflammation EYLG Rojas, BK McConnell, RA Bond The FASEB Journal 34 (S1), 1-1, 2020 | | 2020 |
